Stephen V. Faraone, PhD

JCP
Measuring Executive Function in ADHD With the BRIEF-A
Original Research

November 21, 2022

The BRIEF-A identified executive function deficits in adults with ADHD that added disability beyond that associated with ADHD alone.
Joseph Biederman, Maura L. DiSalvo, Chloe R. Hutt Vater, et al
JCP
Transdiagnostic PRS Prediction of Mood Disorders
Original Research

April 20, 2022

Mood disorders often co-occur with behavior disorders in children and adolescents. This study explored if polygenic risk scores based on external genome-wide association studies of these disorders could improve...
Eric J. Barnett, Joseph Biederman, Alysa E. Doyle, et al
JCP
Original Research

August 24, 2021

Misuse of stimulant medications prescribed for attention-deficit/hyperactivity disorder (ADHD) can have adverse medical outcomes. This study tested the safety and efficacy of AR19, a manipulation-resistant formulation of amphetamine, in...
Stephen V. Faraone, Ann Childress, Steve Caras, et al
JCP
AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adult ADHD
Insight videos

August 24, 2021

AR19, a manipulation-resistant formulation of amphetamine sulfate, was created to address the problem of non-oral use of stimulant medications (eg, smoking, injecting). In this video, Dr Faraone highlights the...
Stephen V. Faraone
JCP
Original Research

June 29, 2021

Many patients with ADHD have “sluggish cognitive tempo,” characterized by daydreaming, being underactive, and feeling spacey and lethargic. This RCT evaluated the use of lisdexamfetamine in adults to reduce...
Lenard A. Adler, Terry L. Leon, Taylor M. Sardoff, et al
JCP
Original Research

December 10, 2019

Children with ADHD often have functional impairments in the early morning and late afternoon and evening. This study sought to establish norms on 2 rating scales to help clinicians...
Stephen V. Faraone, Norberto J. DeSousa, Marina Komolova, et al
JCP
Original Research

May 7, 2019

What factors may predict the onset of ADHD in adolescence? This population-based study used baseline and follow-up phone interviews to identify predictors and evaluate the validity of subthreshold and...
Michel Lecendreux, Michael Silverstein, Eric Konofal, et al
JCP
Meta-Analysis

April 30, 2019

Methylphenidate is related to sleep-related adverse events. This meta-analysis sought to quantify this impact of methylphenidate and determine the varieties of sleep problems associated with this drug.
Stephen V. Faraone, Michelle D. Po, Marina Komolova, et al
JCP
Original Research

August 7, 2018

ADHD symptoms tend to emerge over time, meaning that some children will manifest subsyndromal symptoms of ADHD before they meet full diagnostic criteria. Read this article to learn how...
Joseph Biederman, Maura Fitzgerald, Anna-Mariya Kirova, et al
JCP
Original Research

March 13, 2018

While stimulants are the mainstay of ADHD treatment, their use is marred by concerns about substance abuse. This study involving  37 adults with ADHD looks at whether naltrexone might...
Thomas J. Spencer, Pradeep Bhide, Jinmin Zhu, et al
JCP
Original Research

June 20, 2017

Is there a way to reduce the abuse potential of stimulant medications while retaining their effectiveness in treating ADHD? Read this article by Spencer and colleagues to learn the...
Thomas J. Spencer, Pradeep Bhide, Jinmin Zhu, et al
JCP
Article

October 26, 2016

Bipolar disorder is often comorbid with other diagnoses including conduct disorder and ADHD. Are youth with bipolar disorder also at risk for initiating smoking and substance use? This study...
Timothy E. Wilens, Joseph Biederman, MaryKate Martelon, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe